Progesterone receptor agonists and antagonists

被引：6

作者：

Allan, G ^{[1
]}

Macielag, M ^{[1
]}

机构：

[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 1999年 / 9卷 / 07期

关键词：

contraception; endometriosis; leiomyomata; mifepristone; progestin;

D O I：

10.1517/13543776.9.7.955

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Steroidal progestin agonists have long been used in oral contraceptives, and the progestin antagonist mifepristone is used as an abortifacient. Progestin antagonists are also likely to be useful for treating breast cancer and various gynaecological disorders. This patent review relates to progestin receptor agonists and antagonists, focusing on applications filed over the past three years. Two emerging themes will be elaborated upon: the development of novel steroidal and non-steroidal compounds, and the elucidation of new therapeutic uses for progestin antagonists.

引用

页码：955 / 962

页数：8

共 50 条

[1] Progesterone antagonists and progesterone receptor modulators
Spitz, IM
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (10) : 1693 - 1707
[2] Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists
Lin, Hsiang-Ru
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (15) : 3626 - 3632
[3] Progesterone antagonists and progesterone receptor modulators: an overview
Spitz, IM
STEROIDS, 2003, 68 (10-13) : 981 - 993
[4] Progesterone receptor antagonists
Spitz, Irving M.
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (10) : 882 - 890
[5] Progesterone receptor modulators and progesterone antagonists in women's health
Spitz, IM
Chwalisz, K
STEROIDS, 2000, 65 (10-11) : 807 - 815
[6] Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications
Chabbert-Buffet, N
Meduri, G
Bouchard, P
Spitz, IM
HUMAN REPRODUCTION UPDATE, 2005, 11 (03) : 293 - 307
[7] Clinical applications of progesterone receptor antagonists and selective progesterone receptor modulators
Spitz, IM
ENDOCRINOLOGIST, 2005, 15 (06) : 391 - 400
[8] The use of progesterone antagonists and progesterone receptor modulators in contraception
Spitz, IM
Van Look, PFA
Bennink, HJTC
STEROIDS, 2000, 65 (10-11) : 817 - 823
[9] Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium
Chwalisz, K
Brenner, RM
Fuhrmann, UU
Hess-Stumpp, H
Elger, W
STEROIDS, 2000, 65 (10-11) : 741 - 751
[10] Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists
Washburn, David G.
Hoang, Tram H.
Frazee, James S.
Johnson, Latisha
Hammond, Marlys
Manns, Sharada
Madauss, Kevin P.
Williams, Shawn P.
Duraiswami, Chaya
Tran, Thuy B.
Stewart, Eugene L.
Grygielko, Eugene T.
Glace, Lindsay E.
Trizna, Walter
Nagilla, Rakesh
Bray, Jeffrey D.
Thompson, Scott K.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4664 - 4668

← 1 2 3 4 5 →